Request Demo
Last update 04 Nov 2025
Bacterial DNA gyrase x GR x cPLA2α
Last update 04 Nov 2025
Basic Info
Related Targets |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
ChiCTR2400084341
Observation of the effectiveness of 0.05% cyclosporine eye drops (II) in the treatment of dry eye patients after refractive surgery
CTRI/2010/091/001085
Evaluation of Safety and Efficacy of Loteprednol Etabonate + Gatifloxacin eye drops in the treatment of Post Operative Inflammatory conditions of the Anterior Segment of the Eye.
100 Clinical Results associated with Bacterial DNA gyrase x GR x cPLA2α
Login to view more data
100 Translational Medicine associated with Bacterial DNA gyrase x GR x cPLA2α
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free